Cardiovascular disease and chimeric antigen receptor cellular therapy
Chimeric antigen receptor T-cell (CAR T) therapy is a revolutionary personalized therapy that has significantly impacted the treatment of patients with hematologic malignancies refractory to other therapies. Cytokine release syndrome (CRS) is a major side effect of CAR T therapy that can occur in 70...
Main Authors: | Anjali Rao, Andrew Stewart, Mahmoud Eljalby, Praveen Ramakrishnan, Larry D. Anderson, Farrukh T. Awan, Alvin Chandra, Srilakshmi Vallabhaneni, Kathleen Zhang, Vlad G. Zaha |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.932347/full |
Similar Items
-
Gender Differences in Diagnosis, Prevention, and Treatment of Cardiotoxicity in Cardio-Oncology
by: Shawn Simek, et al.
Published: (2022-09-01) -
Cardiovascular perspectives on stem cell transplant and Car-T cell therapy: The old and the new for assessment and management
by: Anjali Rao, et al.
Published: (2022-10-01) -
Corporate management, governance, and ethics best practices /
by: 174766 Vallabhaneni, S. Rao
Published: (2008) -
Auditing software development : a manual with case studies /
by: 174766 Vallabhaneni, S. Rao
Published: (1990) -
Auditing computer security : a manual with case studies /
by: 174766 Vallabhaneni, S. Rao
Published: (1989)